ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
about
ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@en
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@nl
type
label
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@en
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@nl
prefLabel
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@en
ET-12PHASE II STUDY OF ONARTUZ ...... S WITH RECURRENT GLIOBLASTOMA.
@nl
P2093
P356
P1433
P1476
ET-12PHASE II STUDY OF ONARTUZ ...... TS WITH RECURRENT GLIOBLASTOMA
@en
P2093
Alba A Brandes
Cristobel Belda-Iniesta
David Macdonald
Estela Pineda
Gaetano Finocchiaro
Jean-Marie Bruey
Kirsten Hopkins
Lawrence Recht
Manfred Westphal
P304
P356
10.1093/NEUONC/NOU255.12
P433
P577
2014-11-01T00:00:00Z